Salmonella-associated deaths, Sweden, 1997-2003.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3373115)

Published in Emerg Infect Dis on February 01, 2006

Authors

Anders Ternhag1, Anna Törner, Karl Ekdahl, Johan Giesecke

Author Affiliations

1: Swedish Institute for Infectious Disease Control, Solna, Sweden. anders.ternhag@karolinska.se

Articles by these authors

A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis (2007) 2.93

Is exposure to sick or dead poultry associated with flulike illness?: a population-based study from a rural area in Vietnam with outbreaks of highly pathogenic avian influenza. Arch Intern Med (2006) 2.60

Malaria risk in travelers. Emerg Infect Dis (2005) 1.87

Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J (2002) 1.74

Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol (2007) 1.68

The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis (2002) 1.58

The comparative burden of salmonellosis in the European Union member states, associated and candidate countries. BMC Public Health (2006) 1.54

Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis (2003) 1.50

One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS (2002) 1.44

Intervening to reduce inequalities in infections in Europe. Am J Public Health (2008) 1.41

[Better treatment has reduced AIDS mortality. Increased number of patients with HIV infections will burden the ambulatory care services]. Lakartidningen (2002) 1.40

Timeliness of case reporting in the Swedish statutory surveillance of communicable diseases 1998--2002. Scand J Infect Dis (2004) 1.37

Risk factors for domestic sporadic campylobacteriosis among young children in Sweden. Scand J Infect Dis (2005) 1.34

Emergence and spread of Chlamydia trachomatis variant, Sweden. Emerg Infect Dis (2008) 1.30

Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis (2002) 1.29

Emerging genotype (GGIIb) of norovirus in drinking water, Sweden. Emerg Infect Dis (2003) 1.24

Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis (2008) 1.24

Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect Dis (2006) 1.19

Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology (2005) 1.17

Imported methicillin-resistant Staphylococcus aureus, Sweden. Emerg Infect Dis (2010) 1.16

Effect of regulation and education on reptile-associated salmonellosis. Emerg Infect Dis (2005) 1.13

Parents' reported reasons for avoiding MMR vaccination. A telephone survey. Scand J Prim Health Care (2005) 1.11

'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. Euro Surveill (2005) 1.08

Hepatitis A risk in travelers. J Travel Med (2009) 1.07

Some model based considerations on observing generation times for communicable diseases. Math Biosci (2009) 1.02

Endemic tularemia, Sweden, 2003. Emerg Infect Dis (2005) 0.99

Timeliness of MMR vaccination--influence on vaccination coverage. Vaccine (2004) 0.98

Proposed new International Health Regulations. BMJ (2005) 0.98

Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat (2008) 0.96

Linking environmental drivers to infectious diseases: the European environment and epidemiology network. PLoS Negl Trop Dis (2013) 0.93

The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill (2008) 0.93

Rickettsioses in Swedish travellers, 1997-2001. Scand J Infect Dis (2003) 0.92

Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis (2009) 0.92

Risk factors for developing tuberculosis in remand prisons in St. Petersburg, Russia - a case-control study. Eur J Epidemiol (2007) 0.92

Size matters -- patient organisations exaggerate prevalence numbers. Eur J Epidemiol (2005) 0.91

Travellers returning to Sweden as sentinels for comparative disease incidence in other European countries, campylobacter and giardia infection as examples. Euro Surveill (2004) 0.90

Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev (2011) 0.89

Emergence of new Salmonella Enteritidis phage types in Europe? Surveillance of infections in returning travellers. BMC Med (2004) 0.89

EURISWEB--Web-based epidemiological surveillance of antibiotic-resistant pneumococci in day care centers. BMC Med Inform Decis Mak (2003) 0.89

Mortality following Campylobacter infection: a registry-based linkage study. BMC Infect Dis (2005) 0.89

Epidemiological investigation of a food-borne gastroenteritis outbreak caused by Norwalk-like virus in 30 day-care centres. Scand J Infect Dis (2002) 0.89

Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings. Vaccine (2008) 0.88

A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One (2013) 0.88

Penicillin-resistant pneumococci in Sweden 1997-2003: increased multiresistance despite stable prevalence and decreased antibiotic use. Microb Drug Resist (2006) 0.86

Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country. J Viral Hepat (2008) 0.86

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000-2003, increasing incidence and regional differences. BMC Infect Dis (2006) 0.86

Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002. J Antimicrob Chemother (2005) 0.85

Modelling the spread of penicillin-resistant Streptococcus pneumoniae in day-care and evaluation of intervention. Stat Med (2005) 0.84

Implementing a public web based GIS service for feedback of surveillance data on communicable diseases in Sweden. BMC Infect Dis (2004) 0.83

Travellers returning to Sweden with falciparum malaria: pre-travel advice, behaviour, chemoprophylaxis and diagnostic delay. Scand J Infect Dis (2005) 0.82

Parents' attitudes towards hepatitis B vaccination for their children. A survey comparing paper and web questionnaires, Sweden 2005. BMC Public Health (2007) 0.82

Influenza vaccine coverage and reasons for non-vaccination in a sample of people above 65 years of age, in Sweden, 1998-2000. Scand J Infect Dis (2003) 0.81

Study of developed resistance due to antibiotic treatment of coagulase-negative Staphylococci. Microb Drug Resist (2003) 0.81

Monitoring and assessing vaccine safety: a European perspective. Expert Rev Vaccines (2010) 0.80

Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era. Scand J Infect Dis (2005) 0.80

Nosocomial pneumonia in the ICU: a prospective cohort study. Scand J Infect Dis (2007) 0.79

Modeling pneumococcal resistance to penicillin in southern Sweden using artificial neural networks. Microb Drug Resist (2006) 0.79

A network strategy to advance public health in Europe. Eur J Public Health (2008) 0.79

Enhancing the role of health communication in the prevention of infectious diseases. J Health Commun (2013) 0.78

Detection of a previously uncommon salmonella phage in tourists returning from Europe. Lancet (2002) 0.78

Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers. Scand J Infect Dis (2012) 0.78

The impact of active intervention on the spread of penicillin-resistant Streptococcus pneumoniae in Swedish day-care centres. Scand J Infect Dis (2004) 0.77

Assessing vaccination coverage in the European Union: is it still a challenge? Expert Rev Vaccines (2011) 0.77

H5N1 influenza and the implications for Europe. BMJ (2005) 0.76

Lessons learnt in Europe on tuberculosis surveillance, outbreaks and BCG vaccination in 2011. Eur Respir J (2013) 0.76

Public health need versus sales of antibacterial agents active against multidrug-resistant bacteria: a historical perspective. J Antimicrob Chemother (2013) 0.75

Validity of International Health Regulations in reporting emerging infectious diseases. Emerg Infect Dis (2012) 0.75

[Severe acute respiratory syndrome (SARS). Local infection--global panic]. Lakartidningen (2003) 0.75

[Marburg fever in Angola--the epidemic is over, but the disease is still there]. Lakartidningen (2005) 0.75

Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country. Scand J Gastroenterol (2010) 0.75

[Nepropathia epidemica on the increase and spreading south in Sweden]. Lakartidningen (2005) 0.75

[Fewer young people born in Sweden have contracted HIV]. Lakartidningen (2010) 0.75

[Measles takes root in Sweden again. Reduced vaccination will result in epidemics, about 25 000 cases are expected to occur annually within a 15-year period]. Lakartidningen (2003) 0.75

[Avian influenza--next global infection threat from Asia]. Lakartidningen (2004) 0.75

[World's most rapidly growing HIV epidemic is in Russia. The Russian reporting on HIV infections seems to be reliable]. Lakartidningen (2002) 0.75

[Good guideline compliance among patients and health services when it comes to suspected SARS infection]. Lakartidningen (2004) 0.75

[A/Fujian--a changeable influenza virus which may cause problems during winter]. Lakartidningen (2003) 0.75